Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
3.420
-0.010 (-0.29%)
Apr 30, 2026, 3:04 PM CST
SHE:300026 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,502 | 1,306 | 1,574 | 1,206 | 1,316 |
Cash & Short-Term Investments | 1,502 | 1,306 | 1,574 | 1,206 | 1,316 |
Cash Growth | 15.00% | -17.00% | 30.46% | -8.34% | 16.89% |
Accounts Receivable | 2,572 | 2,825 | 2,892 | 3,546 | 3,694 |
Other Receivables | 33.61 | 38.34 | 50.09 | 49.94 | 59.23 |
Receivables | 2,606 | 2,864 | 2,942 | 3,596 | 3,753 |
Inventory | 1,371 | 1,749 | 1,961 | 2,214 | 1,305 |
Prepaid Expenses | - | 12.5 | 13.25 | 32.11 | 16.77 |
Other Current Assets | 237.67 | 217.18 | 230.06 | 336.93 | 416.22 |
Total Current Assets | 5,717 | 6,149 | 6,720 | 7,385 | 6,806 |
Property, Plant & Equipment | 2,953 | 3,149 | 3,242 | 3,322 | 2,901 |
Long-Term Investments | 178.84 | 235.58 | 247.62 | 244.03 | 272.82 |
Goodwill | 635.6 | 675.2 | 692.54 | 716.05 | 716.05 |
Other Intangible Assets | 267.14 | 298.45 | 331.11 | 352.73 | 313.68 |
Long-Term Accounts Receivable | - | 26.39 | 46.37 | 94.1 | 115.01 |
Long-Term Deferred Tax Assets | 223.41 | 222.17 | 129.29 | 140.56 | 108.16 |
Long-Term Deferred Charges | 393.4 | 386.75 | 402.6 | 327.29 | 311.53 |
Other Long-Term Assets | 23.26 | 22.77 | 23.14 | 77.68 | 62.51 |
Total Assets | 10,392 | 11,165 | 11,835 | 12,660 | 11,607 |
Accounts Payable | 449.97 | 678.15 | 713.45 | 884.77 | 605 |
Accrued Expenses | 42.6 | 299.23 | 184.08 | 444.37 | 519.36 |
Short-Term Debt | 14.85 | 16.24 | 23.18 | 231.47 | 293.79 |
Current Portion of Long-Term Debt | 153.41 | 150.25 | 167.67 | 380.77 | 100.02 |
Current Portion of Leases | - | 45.25 | 25.88 | 55.07 | 45.86 |
Current Income Taxes Payable | 60.44 | 19.4 | 20.61 | 9.82 | 15.12 |
Current Unearned Revenue | 52.03 | 63.97 | 76.27 | 208.03 | 137.56 |
Other Current Liabilities | 508.35 | 348.67 | 353.7 | 463.6 | 341.56 |
Total Current Liabilities | 1,282 | 1,621 | 1,565 | 2,678 | 2,058 |
Long-Term Debt | 260.59 | 529.17 | 1,257 | 1,345 | 1,458 |
Long-Term Leases | 102.25 | 111.16 | 59.42 | 78.12 | 67.07 |
Long-Term Unearned Revenue | 62.03 | 65.56 | 62.56 | 62.04 | 67.55 |
Long-Term Deferred Tax Liabilities | 31.28 | 39.52 | 23.2 | 33.81 | 3.95 |
Total Liabilities | 1,738 | 2,367 | 2,967 | 4,197 | 3,655 |
Common Stock | 3,004 | 3,004 | 3,004 | 3,004 | 3,004 |
Additional Paid-In Capital | 589.89 | 589.89 | 589.49 | 589.49 | 589.49 |
Retained Earnings | 4,971 | 5,043 | 5,112 | 4,695 | 4,199 |
Comprehensive Income & Other | -48.79 | 6.83 | 4.75 | 0.86 | -19.98 |
Total Common Equity | 8,517 | 8,644 | 8,710 | 8,290 | 7,773 |
Minority Interest | 137.68 | 154.66 | 157.7 | 172.87 | 179.49 |
Shareholders' Equity | 8,654 | 8,799 | 8,868 | 8,463 | 7,952 |
Total Liabilities & Equity | 10,392 | 11,165 | 11,835 | 12,660 | 11,607 |
Total Debt | 531.1 | 852.07 | 1,533 | 2,091 | 1,965 |
Net Cash (Debt) | 971.06 | 454.12 | 40.24 | -884.45 | -648.87 |
Net Cash Growth | 113.83% | 1028.45% | - | - | - |
Net Cash Per Share | 0.53 | 0.21 | 0.01 | -0.30 | -0.22 |
Filing Date Shares Outstanding | - | 3,004 | 3,004 | 3,004 | 3,004 |
Total Common Shares Outstanding | - | 3,004 | 3,004 | 3,004 | 3,004 |
Working Capital | 4,435 | 4,528 | 5,155 | 4,707 | 4,748 |
Book Value Per Share | - | 2.88 | 2.90 | 2.76 | 2.59 |
Tangible Book Value | 7,614 | 7,670 | 7,686 | 7,221 | 6,743 |
Tangible Book Value Per Share | - | 2.55 | 2.56 | 2.40 | 2.24 |
Buildings | - | 1,986 | 1,988 | 1,730 | 1,651 |
Machinery | - | 2,544 | 2,514 | 2,155 | 1,852 |
Construction In Progress | - | 104.19 | 54.11 | 461.01 | 232.93 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.